A detailed history of Xml Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Xml Financial, LLC holds 74,485 shares of BMY stock, worth $4.29 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
74,485
Previous 78,996 5.71%
Holding current value
$4.29 Million
Previous $3.28 Million 17.5%
% of portfolio
0.36%
Previous 0.33%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$39.66 - $51.75 $178,906 - $233,444
-4,511 Reduced 5.71%
74,485 $3.85 Million
Q2 2024

Jul 22, 2024

SELL
$40.25 - $52.99 $222,502 - $292,928
-5,528 Reduced 6.54%
78,996 $3.28 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $951,395 - $1.08 Million
-19,829 Reduced 19.0%
84,524 $4.58 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $94,196 - $112,402
1,943 Added 1.9%
104,353 $5.35 Million
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $15,861 - $17,736
274 Added 0.27%
102,410 $5.94 Million
Q2 2023

Aug 07, 2023

BUY
$63.71 - $70.74 $152,266 - $169,068
2,390 Added 2.4%
102,136 $6.53 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $65,841 - $74,679
1,002 Added 1.01%
99,746 $6.91 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $23,694 - $28,057
-346 Reduced 0.35%
98,744 $7.1 Million
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $12,881 - $7.61 Million
99,090 New
99,090 $7.04 Million
Q2 2022

Aug 01, 2022

SELL
$72.62 - $79.98 $7.21 Million - $7.95 Million
-99,347 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $46,417 - $55,658
-755 Reduced 0.75%
99,347 $7.26 Million
Q4 2021

Feb 01, 2022

BUY
$53.63 - $62.52 $319,420 - $372,369
5,956 Added 6.33%
100,102 $6.24 Million
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $5.57 Million - $6.53 Million
94,146 New
94,146 $5.57 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Xml Financial, LLC Portfolio

Follow Xml Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xml Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xml Financial, LLC with notifications on news.